Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • JPM Emerging Markets Income trust to slash performance fee
  • 3 Rules Poor Teens Should Do Follow To Make It To The...
  • Taco Bell Sends Bizarre Love Letters And Rings To Models...
  • Steep Slide in Japan's Yen is 'Very, Very...
  • Canada’s financial community facing changing of the guard
  • The Incredible Story Of America's Boom, Crash, And...
  • ESPN cutting workforce, 'smartly managing costs'
  • Guest Post: Centralization And Sociopathology
  • Somebody Is Scalping A Planet Money T-Shirt For $350
  • Denso executives to plead guilty to price fixing in...

    Chief of Peregrine Financial Group Arrested, Charged

    Fri, 07/13/2012 - 13:56 EDT -

    Federal prosecutors say the chief executive officer of the Peregrine Financial Group has been charged with lying to regulators.

    • Original article
    • Login or register to post comments
     

    Related

    • CEO of troubled Iowa brokerage arrested, charged

    • Peregrine Financial Scion: 'My Father Is Dead To Me'

      SAN FRANCISCO/CHICAGO (Reuters) - Russell Wasendorf Jr., whose father went to prison for stealing $215 million from clients of the futures brokerage they ran together for nearly 20 years, is starting over.

    • CEO of troubled Iowa brokerage in court, charged

    • Peregrine Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript

      Peregrine Pharmaceuticals (PPHM) Q3 2013 Earnings Call March 12, 2013 4:30 pm ET Executives Jay Carlson Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc Joseph S. Shan - Vice President of Clinical & Regulatory Affairs Robert Garnick - Head of Regulatory Affairs

    • Peregrine Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript

      Peregrine Pharmaceuticals (PPHM) Q3 2011 Earnings Call March 11, 2011 4:30 pm ET Executives Joseph Shan - Vice President of Clinical & Regulatory Affairs Steven King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc

    • Peregrine Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

      Peregrine Pharmaceuticals (PPHM) Q1 2013 Earnings Call September 10, 2012 11:00 am ET Executives Jay Carlson Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc Joseph S. Shan - Vice President of Clinical & Regulatory Affairs Robert Garnick - Head of Regulatory Affairs

    • Peregrine Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript

      Peregrine Pharmaceuticals (PPHM) Q4 2012 Earnings Call July 16, 2012 4:30 pm ET Executives Jay Carlson Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc Joseph S. Shan - Vice President of Clinical & Regulatory Affairs

    • Peregrine Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

      Peregrine Pharmaceuticals (PPHM) Q2 2012 Earnings Call December 12, 2011 4:30 pm ET Executives Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc Paul J. Lytle - Chief Financial Officer, Principal Accounting Officer, Corporate Secretary, Chief Financial Officer of Avid Bioservices and Corporate Secretary of Avid Bioservices

    • Peregrine Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

      Peregrine Pharmaceuticals (PPHM) Q1 2012 Earnings Call September 09, 2011 11:30 am ET Executives Unknown Speaker - Robert Garnick - Head of Regulatory Affairs Steven King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc

    • Peregrine Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

      Peregrine Pharmaceuticals (PPHM) Q4 2011 Earnings Call July 14, 2011 4:30 pm ET Executives Unknown Speaker - Robert Garnick - Head of Regulatory Affairs Joseph Shan - Vice President of Clinical & Regulatory Affairs Steven King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc

    Latest

    Study Funded By Candy Trade Group Says Eating Candy Often Won’t Definitely Make You Fat
    Study Funded By Candy Trade Group Says Eating...
    The Xbox One Is Intended To Be An All-In-One Home Entertainment Solution
    The Xbox One Is Intended To Be An All-In-One Home...

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Did Iceland make it through the crisis?
    • Marks & Spenser, Bank Loans in China, Vodafone and Asian Stocks in Our News for Today 05/21/2013
    • Actavis to acquire Warner Chilcott in $5bn pharmaceutical deal

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1672.26 0.36% FTSE: 6803.87 0.71% Nikk.: 15381.02 0.13% DAX: 8472.20 0.19% HSI: 23366.369 -0.54% FX: EUR/GBP: 1.1746 USD/EUR: 1.2909 JPY/USD: 102.5145 Commodities: Gold: 1380.75

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions